ClinicalTrials.Veeva

Menu

Neural Predictors and Neural Changes Associated With Cognitive Behavior Therapy for Obssesive Compulsive Disorder

I

Institut d'Investigació Biomèdica de Bellvitge

Status

Enrolling

Conditions

Obsessive-Compulsive Disorder (OCD)

Treatments

Behavioral: Cognitive-behavior therapy (psychological treatment)

Study type

Interventional

Funder types

Other

Identifiers

NCT04042038
HCB/2018/0681

Details and patient eligibility

About

The goals of the project are 1) to understand what are the neural mechanisms involved in the psychological treatment of obsessive-compulsive disorder (OCD) in children/adolescents and adults, 2) to assess potential differences in the neural mechanisms involved in the psychological treatment of OCD between children/adolescents and adults, and 3) to assess the effectiveness of intensive CBT for children/adolescents and adults with OCD.

Full description

Obsessive-compulsive disorder (OCD) is a frequent and disabling disorder. Cognitive-behavior therapy (CBT) is the best treatment option available for OCD, although it achieves optimum results in less than half of the patients. The investigators will investigate the main neural circuits that predict CBT outcome in OCD and the neural changes associated with CBT in two separate randomized controlled trials (RCTs), one in an adult sample and another in a pediatric sample. In this two RCTs, OCD participants will be randomized to either intensive CBT (20 sessions in 1 month) by a experienced clinician or a waiting-list control (WLC) and will be assessed (by a blind assessor) and scanned before and after CBT. Patients will be offered CBT if they have been randomized to the WLC. At baseline, the investigators will also compare OCD patients with a group of healthy controls (HC). Secondary goals of the project include 1) assessing potential differences between children/adolescents and adults in the neural mechanisms involved in CBT for OCD; 2) assess the effectiveness of intensive CBT for children/adolescents and adults.

Enrollment

120 estimated patients

Sex

All

Ages

8 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: (same for Study 1 and Study 2):

  1. Principal diagnosis of OCD;
  2. Y-BOCS or CYBOCS ≥ 16).
  3. No current psychotropic medication (except benzodiacepines for sleep). 4 ) Age between 8 and 17 years (Study 1) and between 18 and 60 years (Study 2).

Exclusion Criteria: (same for Study 1 and Study 2

  1. Current major depression or current/past psychosis, bipolar disorder or substance abuse.
  2. Developmental disorders (including autistic spectrum disorders).
  3. To be pregnant or during breastfeeding
  4. Current CBT; nt.
  5. Any severe medical disorder ;
  6. Any contraindication for neuroimaging

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

120 participants in 2 patient groups

CBT
Experimental group
Description:
Intensive CBT (20 sessions in 1 month)
Treatment:
Behavioral: Cognitive-behavior therapy (psychological treatment)
Waiting-list
No Intervention group
Description:
Waiting-list

Trial contacts and locations

3

Loading...

Central trial contact

Carles Soriano-Mas, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems